WebThe accuracy (sensitivity and specificity) of PSMA PET/MRI in detecting metastatic or locally recurrent lesion in participants with biochemical recurrence post primary treatment of prostate cancer. The results of the PSMA PET/MRI scan will be compared to other imaging modality available e.g. staging CT, bone scan or standard MRI of the recurrence site … WebOct 26, 2024 · However, MRI and CT have low sensitivity 2,3, and MRI 48 has low specificity for detecting lymph node metastasis 4–6. ... 115 both 18F-PSMA-PET and CT-bone scan. 139 sites of PET positive for metastatic It is made available under a CC-BY-ND 4.0 International license.
Imaging Prostate Cancer: Clinical Utility of Prostate-Specific
WebMay 11, 2024 · Based on the imaging, PSMA PET-CT was 27% more accurate than the standard approach at detecting any metastases (92% versus 65%). Accuracy was … WebMany studies comparing PSMA to 99m Tc-MDP have used PMSA-labeled PET tracers such as 18 F-DCFPyL PET/CT 38 and 68 Ga. 25,39 These studies also reported a higher sensitivity in PSMA-labeled PET tracers compared with 99m Tc-MDP, with sensitivity ranging from 96% to 100% and that of MDP being as low as 73%. supprimer fichier win log files
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer …
WebMar 2, 2024 · Although there are data from some countries pointing toward improved sensitivity, specificity, and cost-effectiveness of PSMA PET on head-to-head comparisons with traditional modalities (CT and bone scan), the prognostic and potential predictive value of PSMA PET has yet to be fully demonstrated. 8 For someone who receives a diagnosis … WebRecently, prostate-specific membrane antigen (PSMA) ligands have presented good results in the diagnosis and treatment of BM from PCa. 7 However, this method is still at the stage of clinical trial and is not acceptable for most patients due to the radiation injury and the high cost. 8,9 The current method for detecting BM in PCa patients is mainly bone scan. WebJan 1, 2024 · The high sensitivity of PSMA PET in localizing recurrent disease has also been shown to significantly affect clinical ... 18 F-FDG PET scans are not recommended by NCCN for staging prostate cancer but are recognized by the Centers for Medicare and Medicaid Studies as having a possible role in assessing response to therapy in ... supprimer fichiers doublons ccleaner